NLRP3 and experimental autoimmune encephalomyelitis: However, our group demonstrated that a gain of function in NLRP3 specifically in CD4+ T cells improved the clinical course of disease in a model of experimental autoimmune encephalomyelitis (EAE), which was associated with a reduction of Th1 and Th17 inflammatory responses and a shift toward a Th2 pattern (58).